1. Home
  2. GEMI vs AVIR Comparison

GEMI vs AVIR Comparison

Compare GEMI & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Gemini Space Station Inc.

GEMI

Gemini Space Station Inc.

HOLD

Current Price

$5.17

Market Cap

536.3M

Sector

N/A

ML Signal

HOLD

Logo Atea Pharmaceuticals Inc.

AVIR

Atea Pharmaceuticals Inc.

HOLD

Current Price

$5.40

Market Cap

434.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GEMI
AVIR
Founded
2014
2012
Country
United States
United States
Employees
650
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
536.3M
434.5M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
GEMI
AVIR
Price
$5.17
$5.40
Analyst Decision
Buy
Buy
Analyst Count
9
1
Target Price
$8.31
$10.00
AVG Volume (30 Days)
1.5M
225.6K
Earning Date
05-14-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.00
EPS
N/A
N/A
Revenue
N/A
$351,367,000.00
Revenue This Year
$35.05
N/A
Revenue Next Year
$39.56
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.91
$2.46
52 Week High
$34.67
$6.45

Technical Indicators

Market Signals
Indicator
GEMI
AVIR
Relative Strength Index (RSI) 54.87 43.96
Support Level $4.01 $5.13
Resistance Level $5.24 $6.37
Average True Range (ATR) 0.32 0.23
MACD 0.14 -0.02
Stochastic Oscillator 86.69 24.58

Price Performance

Historical Comparison
GEMI
AVIR

About GEMI Gemini Space Station Inc.

Gemini Space Station Inc is engaged on unlocking the next era of financial, creative, and personal freedom. It envisions a future where crypto will redesign the global financial system, the internet, and money in a way that provides greater choice, independence, and opportunity for all. As a trusted bridge between the traditional financial system and the emerging crypto economy, It is providing access for individuals and institutions to a decentralized future that is more open, fair, and secure. Its core exchange product has expanded over time to become a comprehensive platform for its users to engage with the crypto economy, including a derivatives exchange, staking services, an over-the-counter (OTC) trading desk, institutional-grade custody, and others.

About AVIR Atea Pharmaceuticals Inc.

Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.

Share on Social Networks: